Tilray Inc (TLRY)
$43.59 0.18 (0.41%)
19:40 EDT TLRY Stock Quote Delayed 15 Minutes
Previous Close $43.59
Market Cap 0
PE Ratio -
Volume (Avg. Vol.) 1.19M
Day's Range 42.69 - 44.10
52-Week Range 21.50 - 300.00
Dividend & Yield N/A (N/A)
TLRY Stock Predictions, Articles, and Tilray Inc News
- From InvestorPlace
- From the Web
Although CRON stock appears to be trading at a deep discount, prospective buyers should take into consideration the coming confluence of technical and fundamental headwinds.
TLRY stock has been, still is, and will remain the most volatile pot stock in the market.
By David Moadel
Tilray may not have done well in terms of the print, but TLRY stock could still jump higher on the company's transformative partnerships.
A share lock-up has boosted TLRY in recent weeks, but Tilray stock will likely continue to fall as fundamentals begin to take hold.
The promise of long-term growth in ACB, TLRY and IIPR is there, but making money in marijuana stocks in today’s speculative market comes down to buying and selling smartly.
Tilray stock has conspicuously taken a beating relative to the major cannabis players, but the underlying company's presence in the U.K. could change the narrative.
By Thomas Niel
Canopy Growth (CGC) is poised to dominate the American cannabis market. But after a weak earnings report, its current sky-high valuation is in question.
Tilray has recently pulled off an impressive rally. Yet it may not last long. Much of the spike was due to an extension of a lock-up provision from the company’s largest shareholder. However, there are some fundamental issues that should concern investors.
The stock charts of Verizon, General Electric and Ventas are ready to end the trading week at key pivot points.
Now that short sellers have been effectively neutered, management can worry about growing Tilray’s business rather than worrying about the TLRY stock price.
Tilray stock has been a dissappointment to investors. I'm no guru, but I don't think that will change anytime soon.
The U.S.-China trade war makes a strong case for buying marijuana penny stocks as full legalization provides an easy catalyst for economic activity and growth.
ACB stock is still a very speculative name, but Aurora Cannabis' management has proven to be wise, and savvy.
TLRY stock popped in early June on a lock-up extension catalyst, but that catalyst won't repeat, so more Tilray news is needed.
The bears have all the reasons to clobber Aurora Canabis. Yet ACB stock is up 59% year to date and 400% overall. The bullish thesis persists.
Aurora Cannabis has been stuck in a downtrend, but will ACB stock be able to breakout? Let's look at the charts to see what's going on.
Less than a year ago, Tilray (NASDAQ:TLRY) traded at an eye-popping $300 a share. But Sept. 19 is a long time ago in the cannabis....
Of course, the medical opportunity is massive, but Tilray competitor, Canopy Growth (NYSE:CGC), has been aggressively pursuing a multi-pronged approach that inherently diversifies the future revenue streams. CGC’s vision for THC as an ingredient in an array of consumer products separates them from an increasingly crowded industry.
TLRY stock is a falling knife with a lot of downside momentum. A positive catalyst could end this downtrend, but there aren't any in sight.
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!